JACIE TOUART: Open Payments
NPI 1598913410 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 21 payments from 14 companies in 2025. Trend: 2023 $709 · 2024 $1,445 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $279 |
| Phathom Pharmaceuticals, Inc. | 1 | $140 |
| CSL Behring | 1 | $122 |
| Tonix Medicines, Inc. | 1 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $86 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $81 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Novo Nordisk Inc | 3 | $53 |
| ABBVIE INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
Products named: TEPEZZA, VOQUEZNA, KRYSTEXXA, Hizentra, TONMYA, RELISTOR, AREXVY, Ozempic.
Industry payments across CA — which companies pay providers there.
